Procter & Gamble Hygiene and Health Care · NSE: PGHH · BSE: 500459
Q2 FY24 results · Jul–Sep 2023
Procter & Gamble Hygiene and Health Care reported revenue from operations of ₹1,138.35 crore (up 8.9% from Q2 FY23) and net profit of ₹210.69 crore (up 36.4% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a standalone basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,138.35 | 1,044.89 | +8.9% | 852.53 | +33.5% |
| Other income | 15.77 | 6.73 | +134.3% | 10.10 | +56.1% |
| Total income | 1,154.12 | 1,051.62 | +9.7% | 862.63 | +33.8% |
| Profit before tax | 284.47 | 205.80 | +38.2% | 206.58 | +37.7% |
| Net profit for the period | 210.69 | 154.41 | +36.4% | 151.24 | +39.3% |
| EPS, basic (₹) | 64.91 | 47.57 | +36.5% | 46.59 | +39.3% |
| Net margin (%) | 18.5 | 14.8 | 17.7 |
Standalone
- Filed with BSE
- 31 Oct 2023, 11:49 IST
- Board meeting
- 30 Oct 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Unaudited
- Source
- XBRL filing on BSE